
Cellebrite begins plans to establish a US parent company
The board-backed reorganization remains subject to shareholder and regulatory approvals, with completion targeted for the first half of 2027.
Read the story
The board-backed reorganization remains subject to shareholder and regulatory approvals, with completion targeted for the first half of 2027.
Read the storyThe Israeli-founded company says it delivered 120 STRIKER systems for the Gauntlet II trials; future contract awards remain uncertain.

Asahi Kasei Medical and Rapha Capital co-led the financing as FIZE expands distribution and develops predictive fluid monitoring.

The Innovation Authority selected Augmenta Health and Intelligent Machine Labs–Foundry, with grants of up to NIS 40 million available to each group.

The Israeli language-learning company plans to double its team, with much of the hiring aimed at AI research and engineering.

The Tel Aviv startup organizes business events in sequence so software agents can analyze how an outcome developed.

Oasis will operate as Cyera Identity, adding controls over access by software, machines and AI agents.

The company raised the money through a convertible note and expects a beta release by the end of 2026.

The independently managed fund would back university research, alumni startups and outside technology ventures.

The defense startup launched publicly with facilities in the United States, Germany and northern Israel.

Insight Partners led the Series C, which valued the AI platform company at $5 billion.

The transaction includes two subsidiaries and gives the Israeli business a central role in Prytek’s customer lifecycle operations.
